Monday, November 25, 2024

DHA Research Funding Opportunity: Accelerating Innovation in Military Medicine – AI and Deep Learning

“Applications to the Fiscal Year 2019 (FY19) Accelerating Innovation in Military Medicine (AIMM) are being solicited for the Defense Health Agency (DHA) J9, Research and Development Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA).”

“… To meet the intent of the award mechanism, applications submitted to the FY19 AIMM must address at least one of the Focus Areas listed:

  • Algorithms/tools for decision support in a deployed or operational environment to: diagnose military-relevant disease, illness, or injury; prescribe mitigation and treatment strategies; and/or determine risk of Warfighter return to duty.
  • Artificial Intelligence (AI)/deep learning for integrating heterogeneous data streams and analyzing data from wearables to support making informed healthcare decisions.1  Wearable sensor systems may pertain to, but are not limited to, the following or combinations of the following:  infectious disease diagnosis; physiologic status monitoring; informing real-time casualty location and triage; and/or environmental monitoring.
  • AI/deep learning for analyzing and interrogating large medical data sets to: identify patterns/predictors of disease, illness, or injury; and/or identify treatment outcomes…”

“Funding for this award mechanism supports applied research.  Applied research utilizes studies to understand the means to meet a recognized and specific need.  It is an expansion and application of knowledge to develop useful materials, devices, and systems or methods…”

“The CDMRP expects to allot approximately $3.0M to fund approximately six AIMM Research Award applications.”

Read more here.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required